The purpose of this study is to collect information about illnesses caused by a virus called respiratory syncytial (sin-SISH-uhl) virus, or “RSV.” RSV is a common virus that circulates in the winter and can cause infections of the respiratory tract (lungs and breathing passages). Symptoms can range from mild cold-like symptoms to severe lower respiratory tract illness.
Older adults have a higher risk of severe RSV infection. In people who already have lung or heart problems, RSV infection can cause those problems to worsen.
There are currently no vaccines available to prevent RSV infection.
The sponsor of this study, Pfizer, is developing a vaccine to try to prevent RSV infection.
We are enrolling adults aged 70 years and older. If you have a medical condition that affects the immune system or take medications that affect the immune system, you may not be in the study. There are also other conditions and circumstances that may make you ineligible for this study.
All study visits will be held at our research clinic in downtown Seattle. The Research Clinic is next to I-5 in the Metropolitan Park East Building at 1730 Minor Ave.
No, both Kaiser Permanente members and non-members can be in this study. You may also refer family and friends to the study.
No, we will give you all study supplies. There will be no co-pay and no charge for any study procedures. Parking and bus tickets are provided at no cost.